NEW YORK – Agilent Technologies said on Wednesday evening that it has priced a public offering of its senior notes in an aggregate principal amount of $850 million.
Agilent expects the net proceeds of the offering to be about $841.1 million and the offering to close on Mar. 12.
The Santa Clara, California-based firm plans to use the net proceeds to fund the redemption of its 3.20 percent senior notes due in 2022, to pay down borrowings under its commercial paper program, and for general corporate purposes.
Barclays Capital, Citigroup Global Markets, and JP Morgan Securities are acting as joint book-running managers on the offering.
The notes will mature in March 2031 and will bear interest at an annual rate of 2.3 percent.
Earlier this week, Agilent said it plans to acquire liquid biopsy firm Resolution Bioscience for up to $695 million.
Agilent's shares were down about 1 percent at $118.19 in Thursday morning trading on the New York Stock Exchange.